JFrog to Present at 28th Annual Needham Growth Conference
Digest more
CEO and Chairman, Dines Daniel, sold shares worth around $1.5 million earlier in the week. ・He sold 90,000 shares of the company in two tranches and still owns roughly 28.5 million shares. ・Retail investors on Stocktwits expect the stock to rally in the coming times.
If you are wondering whether UiPath's share price reflects its true worth or leaves some room on the table, you are in the right place. UiPath's stock closed at US$15.88, with a 5.7% decline over the last 7 days and a 14.
TipRanks on MSN
UiPath price target lowered to $17 from $19 at RBC Capital
RBC Capital lowered the firm’s price target on UiPath (PATH) to $17 from $19 and keeps a Sector Perform rating on the shares. 2026 is likely to be
Today, Dec. 29, 2025, UiPath continues its upward trajectory as Morgan Stanley analysts up their price target.
Learn more about whether Adeia Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
UiPath Inc (NYSE:PATH) shares are moving higher in extended trading on Tuesday after it was announced the company will join the S&P Midcap 400.
Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project reveals how documentation quality, governance, and executive discipline determine whether agentic automation can work in heavily regulated environments.
Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it now trades at roughly $16. Let's see why neither of these AI stocks generated life-changing gains for their early investors -- and if either one is worth buying right now.
UiPath is positioning itself as the bridge connecting humans, systems, and AI. The company has narrowed losses and is approaching profitability. The long-term growth runway is large. 10 stocks we like better than UiPath › UiPath (NYSE: PATH) is back in ...
UiPath, Inc. (NYSE:PATH) shares are trading higher Wednesday after it was announced that the company replace Synovus in the S&P MidCap 400.
A few months back, robotic process automation (RPA) unicorn UiPath raised a huge $750 million round at a valuation of around $35 billion. The capital came ahead of the company’s expected IPO, so its then-new valuation helped provide a measuring stick for ...
TipRanks on MSN
Mixed options sentiment in UiPath with shares down 1.77%
Mixed options sentiment in UiPath (PATH), with shares down 30c near $16.38. Options volume relatively light with 35k contracts traded and calls